BIOMARIN PHARMACEUTICAL INC·4

Mar 7, 4:06 PM ET

Guyer Charles Greg 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 7, 2025

Insider Transaction Report

Form 4
Period: 2025-03-06
Guyer Charles Greg
EVP, Chief Technical Officer
Transactions
  • Sale

    Common Stock

    2025-03-06$71.28/sh7,034$501,35587,655 total
Footnotes (1)
  • [F1]The price in column 4 is the weighted average price. The price actually received ranged from $71.276 to $71.285. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Documents

1 file
  • 4
    wk-form4_1741381578.xmlPrimary

    FORM 4